The Medtronic (NYQ:MDT) share price has risen by 2.63% over the past month and it’s currently trading at 104.77. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue...
|Type||Buy / Hold / Sell|
|Year End 30th Apr||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for MDT
The Medtronic (NYQ:MDT) share price has risen by 1.77% over the past month and it’s currently trading at 95.55. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....
In this article we will quickly re-cap the broker forecasts for Medtronic (NYQ:MDT). The Medtronic share price has risen by 2.07% over the past month and it’s currently trading at 96.97. For investors considering whether to buy, hold o...
The Medtronic (NYQ:MDT) share price has risen by 13.5% over the past month and it’s currently trading at 96.76. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....
Medtronic plc is a global healthcare technology company. It develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. The Company also provides PROPEL and SINUVA, which is bioabsorbable, steroid-eluting implants for sinus patients.
- Geoffrey Martha CHM (51)
- Karen Parkhill CFO (55)
- Carol Surface CHO (55)
- Robert ten Hoedt EVP (60)
- John Liddicoat EVP (57)
- Sean Salmon EVP (56)
- Brett Wall EVP (56)
- Robert White EVP
- Richard Kuntz SVP (64)
- Jennifer Kirk CAO (46)
- Scott Donnelly LED (59)
- Richard Anderson IND (66)
- Craig Arnold IND (61)
- Andrea Goldsmith IND (57)
- Randall Hogan IND (65)
- Kevin Lofton IND (66)
- Elizabeth Nabel IND (69)
- Denise O'Leary IND (63)
- Kendall Powell IND (67)
Latest News for MDT
Upcoming Events for MDT
Dividend For MDT.N - 0.6800 USD
Q1 2023 Medtronic PLC Earnings Release
Q1 2023 Medtronic PLC Earnings Call
Q2 2023 Medtronic PLC Earnings Release
Q2 2023 Medtronic PLC Earnings Call
As of Today at 19:15 UTC, shares in Medtronic are trading at $105.54. This share price information is delayed by 15 minutes.
Shares in Medtronic last closed at $105.54 and the price had moved by -17.8% over the past 365 days. In terms of relative price strength the Medtronic share price has underperformed the S&P500 Index by -13.32% over the past year.
The overall consensus recommendation for Medtronic is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Medtronic dividend yield is 2.34% based on the trailing twelve month period.
Last year, Medtronic paid a total dividend of $2.47, and it currently has a trailing dividend yield of 2.34%. We do not have any data on when Medtronic is to next pay dividends.
We do not have data on when Medtronic is to next pay dividends. The historic dividend yield on Medtronic shares is currently 2.34%.
To buy shares in Medtronic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $105.54, shares in Medtronic had a market capitalisation of $133.40bn.
Here are the trading details for Medtronic:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: MDT
Based on an overall assessment of its quality, value and momentum Medtronic is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Medtronic is $130.56. That is 23.7% above the last closing price of $105.54.
Analysts covering Medtronic currently have a consensus Earnings Per Share (EPS) forecast of $5.66 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medtronic. Over the past six months, its share price has outperformed the S&P500 Index by +11.2%.
As of the last closing price of $105.54, shares in Medtronic were trading -7.11% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medtronic PE ratio based on its reported earnings over the past 12 months is 18.12. The shares last closed at $105.54.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medtronic's management team is headed by:
- Geoffrey Martha - CHM
- Karen Parkhill - CFO
- Carol Surface - CHO
- Robert ten Hoedt - EVP
- John Liddicoat - EVP
- Sean Salmon - EVP
- Brett Wall - EVP
- Robert White - EVP
- Richard Kuntz - SVP
- Jennifer Kirk - CAO
- Scott Donnelly - LED
- Richard Anderson - IND
- Craig Arnold - IND
- Andrea Goldsmith - IND
- Randall Hogan - IND
- Kevin Lofton - IND
- Elizabeth Nabel - IND
- Denise O'Leary - IND
- Kendall Powell - IND